bradykinin, leu(8)-des-arg(9)- has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catanzaro, O; Cueva, F; Frontera, M; Navarro, M; Zuccollo, A | 1 |
| Catanzaro, O; Navarro, M; Zuccollo, A | 1 |
2 other study(ies) available for bradykinin, leu(8)-des-arg(9)- and Alloxan Diabetes
| Article | Year |
|---|---|
The role of the kallikrein-kinin system in type I diabetes (insulitis).
Topics: Animals; Bradykinin; Bradykinin Receptor Antagonists; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Kallikrein-Kinin System; Male; Mice; Mice, Inbred C57BL; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Bradykinin | 1996 |
Effects of B1 and B2 kinin receptor antagonists in diabetic mice.
Topics: Analysis of Variance; Animals; Blood Glucose; Body Weight; Bradykinin; Bradykinin Receptor Antagonists; Diabetes Mellitus, Experimental; Male; Mice; Mice, Inbred C57BL; Streptozocin | 1996 |